Similar articles

• [Fatal disseminated toxoplasmosis after unrelated bone marrow transplantation for myelodysplastic syndrome].

  Kato J, Mori T, Hashimoto N, Yamane A, Sakurai M, Toyama T, Okamoto S. Kato J, et al. Rinsho Ketsueki. 2012 Aug;53(8):774-8. Rinsho Ketsueki. 2012. PMID: 22975819 Japanese.
• Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.

  Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D. Warlick ED, et al. Biol Blood Marrow Transplant. 2009 Jan;15(1):30-8. doi: 10.1016/j.bbmt.2008.10.012. Biol Blood Marrow Transplant. 2009. PMID: 19135940
• A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.

  Kröger N, Schetelig J, Zabelina T, Krüger W, Renges H, Stute N, Schrum J, Kabisch H, Siegert W, Zander AR. Kröger N, et al. Bone Marrow Transplant. 2001 Oct;28(7):643-7. doi: 10.1038/sj.bmt.1703215. Bone Marrow Transplant. 2001. PMID: 11704786
• Bone marrow transplantation in Shwachman-Diamond syndrome.

  Hsu JW, Vogelsang G, Jones RJ, Brodsky RA. Hsu JW, et al. Bone Marrow Transplant. 2002 Aug;30(4):255-8. doi: 10.1038/sj.bmt.1703631. Bone Marrow Transplant. 2002. PMID: 12203143 Review.
• Pulmonary toxoplasmosis in bone marrow transplant recipients: report of two cases and review.

  Sing A, Leitritz L, Roggenkamp A, Kolb HJ, Szabados A, Fingerle V, Autenrieth IB, Heesemann J. Sing A, et al. Clin Infect Dis. 1999 Aug;29(2):429-33. doi: 10.1086/520228. Clin Infect Dis. 1999. PMID: 10476754 Review.